BUY Lupin Limited — Arun Kumar Mantri

Lupin share price target & all analyst calls

byArun Kumar MantriHorizon: NA (inferred Intraday)30 Jun 2026, 7:20 am ISTvia CNBC Awaaz.

Entry₹2,405Stated
Target₹2,468
Total upside +2.62% (call closed)
Stop loss₹2,376-1.21% risk
At expiry₹2,412.230 Jun 2026, 3:20 pm
Expired+0.30%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 10:47 pm IST
2 supporting0 opposing
Supports the BUY call (2)

2 other SEBI-registered advisors have active intraday BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·30 Jun · today

Lupin Limited received tentative approval from the U.S. FDA for Enzalutamide Tablets on June 26, 2026. This is a step towards potential market approval.

NSE · Press Release·26 Jun · 4d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.